abstract
Highlights
- •Appropriate quality indicator thresholds must take into account our complex patients
- •Complete surgical staging and timely administration of chemotherapy warrant attention
- •Existing perioperative quality measures demonstrate excellent compliance
Objectives
Ovarian
cancer quality measures are being developed to improve health care
delivery and outcomes. Our objective is to evaluate compliance with 8
quality indicators proposed by the Society of Gynecologic Oncology.
Methods
Review
of 123 ovarian cancer patients who underwent primary surgical
staging/cytoreduction and chemotherapy from 2010–2012 was undertaken.
Medical records were reviewed, and descriptive statistics were performed
to determine compliance.
Results
A
timely operative report documenting residual disease was dictated for
121/123 (98.4%) patients. Complete surgical staging was performed in
33/55 (60.0%) stage I-IIIB patients, with lymphadenectomy most
frequently omitted. For optimally debulked stage III patients, 52/56
(92.9%) were offered intraperitoneal chemotherapy. Ultimately, 29/56
(51.8%) received this route and 19/56 (33.9%) within 42 days (range
18–48, median 40 days). Clinical trial randomization and co-morbidities
accounted for most cases of non-compliance. All 105 patients for whom
chemotherapy was indicated received platin/taxane therapy, and 79/105
(75.2%) within 42 days (range 4–82, median 37 days). Venous
thromboembolism prophylaxis was provided mechanically in 122/123 (99.2%)
and pharmacologically in 99/123 (80.5%) patients within 24 hours of
surgery. Prophylactic parenteral antibiotics were administered within
60 minutes of cytoreduction in 119/123 (96.7%) and discontinued within
24 hours after surgery in 120/123 (97.6%) cases.
Conclusions
Compliance
with strict definitions of ovarian cancer quality indicators varies
depending on the care delivered and documentation of that care.
Increased attention to comprehensive surgical staging and timely
initiation of chemotherapy appears warranted. With the move toward
value-based payment models, quality indicators will play a significant
role in health care delivery.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.